Neural Therapeutics Inc.
NURL
CNSX
01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 377.50K | 47.20K | 48.40K | 17.10K | 52.50K |
Total Receivables | 7.50K | 21.50K | 20.00K | 15.70K | 13.30K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.10K | 1.10K | 1.10K | -- | -- |
Total Current Assets | 386.00K | 69.90K | 69.50K | 32.70K | 65.70K |
|
|||||
Total Current Assets | 386.00K | 69.90K | 69.50K | 32.70K | 65.70K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 386.00K | 69.90K | 69.50K | 32.70K | 65.70K |
|
|||||
Total Accounts Payable | 46.20K | 75.50K | 44.00K | 35.80K | 60.80K |
Total Accrued Expenses | 146.40K | 203.70K | 169.60K | 79.70K | 216.00K |
Short-term Debt | 8.20K | 8.30K | 8.10K | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 200.90K | 287.50K | 221.70K | 115.50K | 276.80K |
|
|||||
Total Current Liabilities | 200.90K | 287.50K | 221.70K | 115.50K | 276.80K |
Long-Term Debt | 488.30K | 268.10K | 270.40K | 271.70K | 104.30K |
Short-term Debt | 8.20K | 8.30K | 8.10K | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 71.80K | 72.40K | 36.40K | -- |
Total Liabilities | 689.10K | 627.30K | 564.50K | 423.60K | 381.10K |
|
|||||
Common Stock & APIC | 2.04M | 2.09M | 2.11M | 2.12M | 2.18M |
Retained Earnings | -3.01M | -3.04M | -2.99M | -2.86M | -2.84M |
Treasury Stock & Other | 662.20K | 392.60K | 390.60K | 347.10K | 351.00K |
Total Common Equity | -303.10K | -557.50K | -495.00K | -390.80K | -315.40K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -303.10K | -557.50K | -495.00K | -390.80K | -315.40K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -303.10K | -557.50K | -495.00K | -390.80K | -315.40K |
|